The importance of co-morbidity in older HIV-infected patients [1]

AIDS

Volumn 17, Issue 10, 2003, Pages 1577-

  Skiest, Daniel J ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMORBIDITY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; LETTER; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL;

EID: 0041366946     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-200307040-00025     Document Type: Letter

References (4)

1. Tumbarello M, Rabagliati R, de Gaetano Donati K, Bertagnolio S, Tamburrini E, Tacconelli E, et al. Older HIV-positive patients in the era of highly active antiretroviral therapy: changing of a scenario. AIDS 2003; 17:128-131.
2. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chron Dis 1987; 40:373-383.
3. Ena J, Valls V, Lopez Aldeguer J, del Pilar Garcia Gasco M, Anon S, Navarro V, et al. Clinical presentation of HIV infection in patients aged 50 years or older. J Infect 1998; 37:213-216.
4. Skiest DJ, Rubinstien E, Carley N, Gioiella L, Lyons R. The importance of comorbidity in HIV infected patients over 55: a retrospective case-control study. Am J Med 1996; 101:605-611.